Abstract:The aim of this research is to study the phenotype, genotype, treatment strategies, and short-term prognosis of Chinese children with ATP1A3 (Na+/K+-ATPase alpha 3 gene)-related disorders in Southwest China. Patients with pathogenic ATP1A3 variants identified using next-generation sequencing were registered at the Children's Hospital of Chongqing Medical University from December 2015 to May 2019. We followed them as a cohort and analyzed their clinical data. Eleven patients were identified with de novo pathogenic ATP1A3 heterozygous variants. One (c.2542 + 1G > T, splicing) has not been reported. Eight patients with alternating hemiplegia of childhood (AHC), one with cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS), and two with relapsing encephalopathy with cerebellar ataxia (RECA) were included. The initial manifestations of AHC included hemiplegia, oculomotor abnormalities, and seizures, and the most common trigger was an upper respiratory tract infection without fever. All patients had paroxysmal hemiplegic attacks during their disease course. The brain MRI showed no abnormalities. Six out of eight AHC cases reached a stable disease state after treatment. The initial symptom of the patient with CAPOS was ataxia followed by developmental regression, seizures, deafness, visual impairment, and dysarthria, and the brain MRI indicated mild cerebellar atrophy. No fluctuation was noted after using Acetazolamide. The initial manifestations of the two RECA cases were dystonia and encephalopathy, respectively. One manifested a rapid-onset course of dystonia triggered by a fever followed by dysarthria and action tremors, and independent walking was impossible. The brain MRI image was normal. The other one presented with disturbance of consciousness, seizures, sleep disturbance, tremor, and dyskinesias. The EEG revealed a slow background (δ activity), and the brain MRI result was normal. No response to Flunarizine was noted for them, and it took 61 and 60 months for them to reach a stable disease state, respectively. Conclusion: Pathogenic ATP1A3 variants play an essential role in the pathogenesis of Sodium-Potassium pump disorders, and AHC is the most common phenotype. The treatment strategies and prognosis depend on the phenotype categories caused by different variation sites and types. The correlation between the genotype and phenotype requires further exploration. What is known: • Pathogenic heterozygous ATP1A3 variants cause a spectrum of neurological phenotypes, and ATP1A3-disorders are viewed as a phenotypic continuum presenting with atypical and overlapping features. • The genotype-phenotype correlation of ATP1A3-disorders remains unclear. What is new: • In this study, the genotypes and phenotypes of ATP1A3-related disorders from Southwest of China were described. The splice-site variation c.2542+1G>T was detected for the first time in ATP1A3-related disorders. • The prognosis of twins with AHC p. Gly947Arg was more serious than AHC cases with other variants, which was inconsistent with previous reports. The phenomenon indicated the diversity of the correlation between the genotype and phenotype.

Synonymous variants in the ATP6AP2 gene may lead to developmental and epileptic encephalopathy

[Developmental and epileptic encephalopathy produced by the ATP1A2 mutation]

ATP6V0C gene variants were identified in individuals with epilepsy, with or without developmental delay

A Heterozygous Pathogenic Variant in the ATP6V1A Gene Triggering Epilepsy in a Large Chinese Pedigree.

Expanding the Spectrum of Autosomal Dominant ATP6V1A-Related Disease: Case Report and Literature Review

ATP6V0C variants impair V-ATPase function causing a neurodevelopmental disorder often associated with epilepsy

ATP6AP2 Variant Impairs CNS Development and Neuronal Survival to Cause Fulminant Neurodegeneration

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

ATP1A2‐related epileptic encephalopathy and movement disorder: Clinical features of three novel patients

A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes

ATP1A1 De Novo Mutation-Related Disorders: Clinical and Genetic Features

A Heterozygous Missense Variant in the YWHAG Gene Causing Developmental and Epileptic Encephalopathy 56 in a Chinese Family.

Variants of ATP1A3 in residue 756 cause a separate phenotype of relapsing encephalopathy with cerebellar ataxia (RECA)-Report of two cases and literature review

A SCN8A variant associated with severe early onset epilepsy and developmental delay: Loss- or gain-of-function?

ATP1A3-related phenotypes in Chinese children: AHC, CAPOS, and RECA

Electrophysiological Features: the Next Precise Step for SCN2A Developmental Epileptic Encephalopathy

De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects

De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy

<i>SZT2</i> variants associated with partial epilepsy or epileptic encephalopathy and the genotype-phenotype correlation

Epilepsy due to potential loss of ATP6V1B2 function with mechanistic insight by a Drosophila Vha55 model

[Genotype and Phenotype of Children with KCNA2 Gene Related Developmental and Epileptic Encephalopathy].